Qube Research & Technologies LTD Aldeyra Therapeutics, Inc. Transaction History

Qube Research & Technologies LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.47 - $6.06 $22,974 - $94,711	15,629 New	15,629 $54,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $125,422 - $215,848	21,737 Added 38.26%	78,556 $780,000
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $107,142 - $149,535	21,091 Added 59.03%	56,819 $395,000
Q3 2022 Nov 14, 2022	BUY	$3.8 - $7.74 $61,989 - $126,262	16,313 Added 84.02%	35,728 $191,000
Q2 2022 Aug 15, 2022	BUY	$2.43 - $4.85 $47,178 - $94,162	19,415 New	19,415 $77,000
Q4 2021 Feb 01, 2022	SELL	$3.5 - $9.63 $152,106 - $418,510	-43,459 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$7.94 - $11.31 $40,009 - $56,991	-5,039 Reduced 10.39%	43,459 $382,000
Q2 2021 Aug 13, 2021	SELL	$10.44 - $14.85 $94,001 - $133,709	-9,004 Reduced 15.66%	48,498 $549,000
Q1 2021 May 14, 2021	SELL	$6.53 - $14.42 $618,306 - $1.37 Million	-94,687 Reduced 62.22%	57,502 $683,000
Q4 2020 Feb 16, 2021	BUY	$6.31 - $8.13 $683,391 - $880,503	108,303 Added 246.78%	152,189 $1.04 Million
Q3 2020 Nov 12, 2020	BUY	$4.0 - $7.53 $93,024 - $175,117	23,256 Added 112.73%	43,886 $325,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $5.05 $40,641 - $104,181	20,630 New	20,630 $86,000

117

36.4M

196K

142K

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $276M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.